FY2026 Earnings Estimate for UNH Issued By Cantor Fitzgerald

UnitedHealth Group Incorporated (NYSE:UNH) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for shares of UnitedHealth Group in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst S. James expects that the healthcare conglomerate will post earnings per share of $26.65 for the year. The consensus estimate for UnitedHealth Group’s current full-year earnings is $29.54 per share.

A number of other research firms have also recently weighed in on UNH. Raymond James cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Erste Group Bank cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Morgan Stanley cut their price target on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. TD Securities reiterated a “hold” rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, Robert W. Baird dropped their target price on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $428.43.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $303.89 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a fifty day moving average price of $399.88 and a 200 day moving average price of $479.36. The stock has a market cap of $275.67 billion, a PE ratio of 19.61, a P/E/G ratio of 1.37 and a beta of 0.44. UnitedHealth Group has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the business earned $6.91 earnings per share.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $28,000. Bayforest Capital Ltd lifted its holdings in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the 4th quarter worth approximately $30,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director now owns 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John F. Rex purchased 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now directly owns 203,796 shares of the company’s stock, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 over the last three months. 0.33% of the stock is owned by insiders.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.91%. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.